Dr Simon Tsoi investigated the association between body weight and tocilizumab effectiveness in rheumatoid arthritis, using data from the BSRBR-RA study. The results were published in the Rheumatology journal.Β What was already known?Tocilizumab is a type of treatment...
Category: Study results
JAK Inhibitors in the BSRBR-RA
Read about some of the recent research from BSRBR-RA looking at JAK inhibitors. Bit of background about you Hello, my name is Zixing Tian, I am an epidemiologist with a research focus on rheumatoid arthritis (RA). I work on the BSRBR-RA study, where I recently...
New results from the study: Research on bDMARDs and Rheumatoid Arthritis
We are happy to share our latest research findings: 'Evaluation of serious infections, including Mycobacterium tuberculosis, during treatment with biologic disease-modifying antirheumatic drugs: does line of therapy matter?' This analysis, performed by Dr Kim Lauper,...
Switching from the original etanercept (the originator) to an etanercept biosimilar for rheumatoid arthritis (RA) β patients do just as well as those who remained on the originator.
Researchers: Lianne Kearsley-Fleet, Aasiyah Rokad, Man-Fung Tsoi, Sizheng Steven Zhao, Mark Lunt, Kath D. Watson, BSRBR-RA Contributors Group, Kimme L. Hyrich. What was already known? Etanercept is one of the main treatment options for patients with rheumatoid...
BSRBR-RA featured on Talking Rheumatology Spotlight podcast!
Prof Kimme Hyrich and Dr Kath Watson from the BSRBR-RA talk to Dr Roz Benson about all things registry, including why the registry was set up, the volume of data (it's big!), publications, high impact papers and ways to get involved. Related ...
Recent Comments